Skip to main content
. 2017 Apr 25;7(4):e1105. doi: 10.1038/tp.2017.40

Table 1. Samples clinical characteristics.

  Major depression Healthy control P
Primary sample
 n 20 19  
 Age, years 29.55 (6.59) 30.05 (6.71) 0.81
 Male/female 2, 18 2, 18 1
 MÅDRS 27.25 (4.24) 0.95 (1.39) <0.001
 HDRS anxiety subscale 4.95 (2.48) 0.21 (0.42) <0.001
 RRS 56.00 (10.23) 29.67 (6.44) <0.001
 Time since illness onset, years 6.35 (6.41) — —
 Comorbid diagnoses None — —
 Hospitalizations 0 — —
 Number of episodes 1.5 (1.25) — —
       
Validation sample
 n 19 19  
 Age, years 32.34 (10.62) 31.91 (10.30) 0.90
 Male/female 7, 12 6, 13a 0.73
 MÅDRS 30.74 (7.31) 1.37 (1.86) <0.001
 HDRS anxiety subscale 7.16 (1.30) 0.31 (0.58) <0.001
 RRS 66.47 (8.22) 30.63 (6.83) <0.001
 Time since illness onset, years 13.50 (8.26) — —
 Comorbid diagnoses N=12 (9 GAD, 5 SAD, 4 OCD, 2 PD, 2 PTSD, 1 historic substance abuse) — —
 Hospitalizations 4 — —
 Number of episodes 4 (2.5) — —

Abbreviations: GAD, generalized anxiety disorder; HDRS, Hamilton Depression Rating Scale (17 item); MÅDRS, Montgomery-Åsberg Depression Rating Scale; OCD, obsessive compulsive disorder; PD, panic disorder; PTSD, post-traumatic stress disorder; RRS, Ruminative Response Scale; SAD, social anxiety disorder.

a

Demographics for the validation sample represent the 19 healthy controls included in the final analysis. The samples did not differ on depression severity (t(37)=−1.83, P=0.07). The validation sample had a significantly higher anxiety score (t(37)=3.45, P=0.001), time since illness onset (t(37)=2.62, P=0.01) and RRS score (t(37)=3.51, P=0.001) than the primary sample.

Values are reported as mean (standard deviations) for all variables except number of episodes where due to skewed data we report median (interquartile range).